´ÜÀåÁõÈıº ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ¾àÁ¦ Ŭ·¡½ºº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Short Bowel Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Distribution Channel, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1667877
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,286,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,682,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,175,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ´ÜÀåÁõÈıº(SBS) ½ÃÀåÀº 2024³â 8¾ï 5,402¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ(CAGR) 6.73%¸¦ ±â·ÏÇϸç 2030³â¿¡´Â 12¾ï 6,538¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

SBS´Â ¼ÒÈ­±â°è, ƯÈ÷ ¼ÒÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Èñ±ÍÇÏ°í ¼è¾àÇØÁö´Â ÁúȯÀ¸·Î SBS ȯÀÚ´Â ¿µ¾ç ¹× ¼öºÐ Èí¼ö ´É·ÂÀÌ ÀúÇÏµÇ¾î ¿µ¾ç½ÇÁ¶, Å»¼ö ¹× ±âŸ ´Ù¾çÇÑ °Ç°­ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ±Ù ¸î ³âµ¿¾È ¼¼°è SBS ½ÃÀåÀº Å« ÁøÀüÀ» ÀÌ·ç¸ç ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô »õ·Î¿î Èñ¸ÁÀ» °¡Á®´ÙÁÖ¾ú½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 8¾ï 5,402¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 12¾ï 6,538¸¸ ´Þ·¯
CAGR : 2025-2030³â 6.73%
±Þ¼ºÀå ºÎ¹® ±Û·çŸ¹Î
ÃÖ´ë ½ÃÀå ºÏ¹Ì

SBS´Â ÀϹÝÀûÀ¸·Î ¼ÒÀåÀÇ »ó´ç ºÎºÐÀÌ ¿Ü°úÀûÀ¸·Î ÀýÁ¦µÇ°Å³ª ¼Õ»óµÇ¾î ¹ß»ýÇÕ´Ï´Ù. ¼±ÃµÀû °á¼Õ, ¿Ü»ó, Å©·Ðº´°ú °°Àº Áúȯ µîÀÇ ¿äÀÎÀÌ ¿øÀÎÀÎ °æ¿ì°¡ ¸¹½À´Ï´Ù. 'Å©·Ðº´ÀÇ Ç¥ÇöÇü°ú µ¿¹Ý Áúȯ, ¼ö¼ú À§Çè, ¾à¼öó¸®, ºñ¾à¼ö󸮿ÍÀÇ ¿¬°ü¼º'À̶ó´Â Á¦¸ñÀÇ ÃÖ±Ù ¿¬±¸¿¡ µû¸£¸é, Å©·Ðº´ÀÇ Ç¥ÇöÇü°ú µ¿¹Ý Áúȯ, ¼ö¼ú À§Çè, ¾à¼öó¸®, ºñ¾à¼ö󸮿ÍÀÇ ¿¬°ü¼º, Å©·Ðº´ÀÇ Ç¥ÇöÇü°ú µ¿¹Ý Áúȯ, ¼ö¼ú À§Çè, ¾à¼öó¸®, ºñ¾à¼ö󸮿ÍÀÇ ¿¬°ü¼º, Å©·Ðº´ÀÇ Ç¥ÇöÇü°ú µ¿¹Ý Áúȯ, ¼ö¼ú À§Çè, ¾à¼öó¸®, ºñ¾à¼ö󸮿ÍÀÇ ¿¬°ü¼ºÀÌ ÀÖ´Ù: The MAGIC in IMAGINE Study"¶ó´Â Á¦¸ñÀÇ ÃÖ±Ù ¿¬±¸¿¡¼­´Â ÀϺ»¿¡¼­ Å©·Ðº´(CD)À¸·Î »õ·Î Áø´Ü¹ÞÀº ¼ºÀÎ 673¸íÀ» ´ë»óÀ¸·Î ÇÑ ¿¬±¸¿¡¼­ 63%°¡ ¿°Áõ¼º Ç¥ÇöÇüÀ» º¸¿´°í, 60%°¡ ȸÀå º´º¯, 49%°¡ Ç×¹® ÁÖÀ§ º´º¯, Ç×¹® ÁÖÀ§ º´º¯(³ó¾ç, ´©°ø µî)ÀÇ À¯º´·üÀÌ µÎµå·¯Áö°Ô ³ô¾Ò½À´Ï´Ù. À¯º´·üÀÌ ´«¿¡ ¶ç°Ô ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¾Æ½Ã¾Æ Áö¿ªÀÇ Á¶»ç¿¡¼­´Â ¿°Áõ¼º ÁúȯÀÇ À¯º´·üÀÌ 66%¿¡¼­ 81%·Î ´õ ³ôÀº °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

ÁÖ¿ä ½ÃÀå À̽´

ÁÖ¿ä ½ÃÀå µ¿Çâ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ ´ÜÀåÁõÈıº ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ´ÜÀåÁõÈıº ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ´ÜÀåÁõÈıº ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´ÜÀåÁõÈıº ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ´ÜÀåÁõÈıº ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ´ÜÀåÁõÈıº ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå PorterÀÇ Five Forces ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ¸®¼­Ä¡»ç¿¡ ´ëÇØ & ¸éÃ¥»çÇ×

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global Short Bowel Syndrome (SBS) market was valued at USD 854.02 million in 2024 and is projected to reach USD 1,265.38 million by 2030, reflecting a compound annual growth rate (CAGR) of 6.73% over the forecast period. SBS is a rare and debilitating condition that impacts the digestive system, particularly the small intestine. Individuals with SBS experience a reduced ability to absorb nutrients and fluids, which can result in malnutrition, dehydration, and various other health complications. In recent years, the global SBS market has experienced significant advancements, bringing new hope to patients and healthcare providers alike.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 854.02 Million
Market Size 2030USD 1265.38 Million
CAGR 2025-20306.73%
Fastest Growing SegmentGlutamine
Largest MarketNorth America

SBS typically arises from the surgical removal or damage of a substantial portion of the small intestine, often caused by factors such as congenital defects, trauma, or diseases like Crohn's disease. According to a recent study titled "Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications, and Nonmedication Approaches: The MAGIC in IMAGINE Study", a study in Japan on 673 newly diagnosed adults with Crohn's disease (CD) found that 63% exhibited an inflammatory phenotype, 60% had ileocolonic disease, and 49% had perianal lesions, with the prevalence of perianal disease (such as abscesses or fistulas) being notably high. Studies across Asia have reported even higher rates of inflammatory disease, ranging from 66% to 81%.

Key Market Drivers

The increasing incidence of Short Bowel Syndrome is driving market growth. As the number of SBS cases rises, the demand for treatments and therapies has surged, contributing to the market's expansion. Pharmaceutical companies are heavily investing in research and development to create medications that enhance nutrient absorption for SBS patients and help them manage their condition. These innovations are a significant factor in the market's growth. Parenteral nutrition, which delivers essential nutrients intravenously, has become a critical treatment for SBS patients, leading to a rise in demand for these solutions and associated equipment. Additionally, enteral nutrition, involving specialized formulas designed for SBS patients, plays a crucial role in managing the condition. Advances in minimally invasive surgical techniques and small bowel transplantation have also improved patient outcomes, further driving market expansion. Increased awareness of SBS and the advocacy efforts of patient groups have led to additional research funding and resources, fostering further market growth. Although SBS is rare, with an estimated prevalence of 1-2 cases per 100,000 individuals annually, its growing recognition is accelerating the development of treatment options.

Key Market Challenges

A major challenge for the SBS market is the limited patient pool. As SBS is classified as a rare disease, the number of diagnosed cases globally is relatively small, limiting the overall market size and the number of patients requiring specialized treatments. This restricted patient base can deter pharmaceutical companies from investing heavily in the development of new therapies, as the potential return on investment is lower. Consequently, promising treatments may not receive the attention they deserve, hindering progress in the field. Additionally, the fragmented nature of the patient pool complicates large-scale clinical trials and the collection of sufficient data to prove the efficacy of new therapies, creating a cycle of underinvestment and delayed progress.

Key Market Trends

Technological advancements have significantly influenced the growth of the global SBS market. Recent medical innovations are improving the management and treatment of SBS, offering hope for affected individuals. Pharmaceutical companies are actively developing new drugs and therapies to address the causes and symptoms of SBS. A notable advancement is Zealand Pharma A/S's phase 3 study of Glepaglutide, a long-acting GLP-2 analog that could potentially outperform existing treatments, such as Teduglutide, due to its benefits, including weekly administration and extended action. Furthermore, the development of specialized nutritional supplements tailored for SBS patients has greatly improved their quality of life.

Key Market Players

Report Scope

This report provides a detailed analysis of the global Short Bowel Syndrome market, segmented into the following categories, in addition to examining industry trends:

By Drug Class:

By Distribution Channel:

By Region:

Competitive Landscape

This report includes detailed profiles of the leading companies operating in the SBS market.

Available Customizations: TechSci Research offers tailored customizations of the Global Short Bowel Syndrome market report to meet specific business requirements. The following customization options are available:

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Short Bowel Syndrome Market Outlook

6. North America Short Bowel Syndrome Market Outlook

7. Europe Short Bowel Syndrome Market Outlook

8. Asia-Pacific Short Bowel Syndrome Market Outlook

9. South America Short Bowel Syndrome Market Outlook

10. Middle East and Africa Short Bowel Syndrome Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Porter's Five Forces Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â